4.5 Article

Short-term ACE inhibition confers long-term protection against target organ damage

Journal

HYPERTENSION RESEARCH
Volume 35, Issue 6, Pages 604-610

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/hr.2012.2

Keywords

ACE inhibitor; cardiac fibrosis; macrophage; renal fibrosis; spontaneously hypertensive rat

Funding

  1. Canadian Institutes of Health Research
  2. Heart & Stroke Foundation of Canada

Ask authors/readers for more resources

Angiotensin converting enzyme (ACE) inhibitors reduce left ventricular (LV) hypertrophy and cardiovascular-renal fibrosis. Experimentally, changes in the LV and kidney persist even after cessation of treatment. The present study investigates whether brief ACE inhibition in spontaneously hypertensive rats (SHR) provides long-term protection against the LV and kidney damage induced by the nitric oxide synthase inhibitor N-omega-nitro-L-arginine-methyl ester (L-NAME). SHR received the ACE inhibitor enalapril (n = 36) or tap water (n = 36). In all, 12 control and treated SHR were sacrificed after 2 weeks and remaining rats were taken off-treatment. After a 2-week washout, 12 controls or previously treated SHR were sacrificed and remaining rats were treated with L-NAME ((control (Con)+L, enalapril (Enal)+L) for 10 days. At sacrifice, blood pressure was recorded via carotid artery cannulation in anesthetized rats, and blood, the kidney and LV were isolated for analysis. LV mass and arterial pressure were significantly reduced by enalapril. LV mass showed a persistent reduction throughout the study. In LV, prior enalapril treatment provided significant (P<0.05) protection against L-NAME-induced increases in proliferating cells (Con+L: 11+/-10.0mm(2) vs. Enal+L: 4+/-4.4mm(2)), interstitial fibrosis (Con+L: 3+/-2.5% vs. Enal+L: 1+/-1.0%) and tissue macrophages (Con+L: 12+/-9mm(2) vs. Enal+L: 5+/-3.6mm(2)). In the kidney, prior enalapril treatment protected against L-NAME-induced interstitial fibrosis and vascular injury. There was no difference in glomerular size or glomerulosclerosis regardless of prior treatment. Plasma creatinine and urea were significantly increased in L-NAME treated rats. This study suggests that brief ACE inhibition confers protection against future heart and kidney injury, even in the absence of continued antihypertensive treatment. Hypertension Research (2012) 35, 604-610; doi:10.1038/hr.2012.2; published online 9 February 2012

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available